Autologous SCT in Hematologic Cancers

The Korea University bone marrow transplantation registry is a longitudinal cohort containing data of patients who underwent SCT at the Korea University Medical Center (Korea University Anam, Guro, and Ansan Hospitals) from January 2007 to December 2018. According to this registry, 201 patients underwent auto-SCT: 107 with multiple myeloma; 50 with B-cell lymphoma; 35 with T-cell lymphoma; 8 with Hodgkin lymphoma, and 1 with amyloid light-chain (AL) amyloidosis. Patients with AL amyloidosis were excluded because critical medical data were missing. Of the 200 patients, 50 were not tested for CMV reactivation. Thus, we retrospectively analyzed data from 150 patients with multiple myeloma (n = 80), B-cell lymphoma (n = 39), T-cell lymphoma (n = 26), and Hodgkin lymphoma (n = 5). All methods were performed in accordance with relevant guidelines and regulations. This study was approved by the Institutional Review Board of the Korea University Medical Center, with a waiver of informed consent for the collection and analysis of retrospective data.

Free full text: Click here

Lee B.H., Jeon M.J., Yu E.S., Kang K.W., Kim D.S., Lee S.R., Park Y., Sung H.J., Choi C.W, & Kim B.S. (2023). Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation. International Journal of Medical Sciences, 20(2), 186-193.

Publication 2023

Amyloid Amyloidosis B cell lymphoma Bone marrow transplantation Hodgkin lymphoma Institutional review board Light Multiple myeloma Patients T cell lymphoma

Corresponding Organization :

Other organizations : Korea University

Top 5 similar protocols

Variable analysis

independent variables

Type of hematological malignancy (multiple myeloma, B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma)

dependent variables

CMV reactivation

control variables

Retrospective data analysis of patients who underwent auto-SCT at the Korea University Medical Center from January 2007 to December 2018
Exclusion of patients with amyloid light-chain (AL) amyloidosis due to missing critical medical data
Institutional Review Board approval with a waiver of informed consent

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!